Figure 1.
Tumor volumes in nude mice bearing H-128 human SCLC (•, control) during treatment with BN/GRP antagonist RC-3095 (▪), administered s.c. at a dose of 20 μg/day per animal. Vertical bars represent SE. ∗∗, P < 0.01 vs. control.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.